Last reviewed · How we verify
Nitroglycerin Ointment 2%
At a glance
| Generic name | Nitroglycerin Ointment 2% |
|---|---|
| Also known as | NITROCARD |
| Sponsor | Mohammad Ali Nazarinia |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Nitroglycerin Ointment for Pain Relief After Endoscopic Hemorrhoid Band Ligation (PHASE4)
- Comparing of Sesame Oil, Nitroglycerin Ointment, and Aloe Vera Gel (PHASE2)
- Enhancing Wound Perfusion in High-Risk Lower Extremity Orthopaedic Surgery: A Study on Nitropaste Using Intraoperative SPY Imaging. (PHASE1)
- Efficacy and Safety of GTN vs. Nifedipine in Acute Anal Fissure: A Clinical Trial (PHASE4)
- Effect of Nitropaste in Chest Masculinizing Surgery (PHASE4)
- The Use of Platelet-rich Plasma in the Treatment of Chronic Anal Fissure (PHASE3)
- Comparison of Injections of Botulinum Toxin and Topical Nitroglycerin Ointment for the Treatment of Chronic Anal Fissure (NA)
- Safety and Tolerability of Nitro for Radial Artery Dilation (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nitroglycerin Ointment 2% CI brief — competitive landscape report
- Nitroglycerin Ointment 2% updates RSS · CI watch RSS
- Mohammad Ali Nazarinia portfolio CI